Shares of Netflix Inc. (NFLX) endured massive double-digit losses after the closing bell Wednesday following the Q2 earnings release. The streaming giant reported some of its worst user numbers in years, leading investors to rake the stock over the coals and drag it toward the lowest levels of 2019. While most public companies traditionally rely […]
Read MoreTrade Setup Buy Target $1.52 Sell Target $1.68 Trailing Stop 20% vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops orally administered small molecule drug candidates to fill unmet medical needs. The company is developing Azeliragon, an orally administered, small molecule antagonist targeting the receptor for advanced glycation endproducts, which is in Phase II/III […]
Read MoreOne of the challenges that most people have to grapple with if they’re new to investing is the volume of data that generally needs to absorbed to determine if a stock is a useful investing opportunity. Depending on who you talk to and the investing method they prefer, you’ll find that there are as many […]
Read More